| ［1］ Broekmans FJ, Kwee J, Hendriks DJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome［J］. Hum Reprod Update,2006,12(6):685-718.［2］ van Rooij IA, Broekmans FJ, Hunault CC, et al. Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility［J］. Reprod Biomed Online,2006,12(2):182-190.［3］ La Marca A, Giulini S, Tirelli A, et al. Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology［J］. Hum Reprod,2007,22(3):766-771.［4］ Baird DT, Collins J, Egozcue J, et al. Fertility and aging［J］. Hum Reprod Update,2005,11(3):261-276.［5］ Franasiak JM, Forman EJ, Hong KH, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening［J］. Fertil Steril,2014,101(3):656-663.［6］ Yong PY, Baird DT, Thong KJ, et al. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation［J］. Hum Reprod,2003,18(1):35-44.［7］ Vural B, Cakiroglu Y, Vural F, et al. Hormonal and functional biomarkers in ovarian response［J］. Arch Gynecol Obstet,2014,289(6):1355-1361.［8］ Seckin B, Turkcapar F, Ozaksit G. Elevated day 3 FSH/LH ratio: a marker to predict IVF outcome in young and older women［J］. J Assist Reprod Genet,2012,29(3):231-236.［9］ Orvieto R, Meltzer S, Rabinson J, et al. Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?［J］. Fertil Steril,2008,90(4):1297-1300.［10］ Nelson SM. Biomarkers of ovarian response: current and future applications［J］. Fertil Steril,2013,99(4):963-969.［11］ Broekmans FJ, de Ziegler D, Howles CM, et al. The antral follicle count: practical recommendations for better standardization［J］. Fertil Steril,2010,94(3):1044-1051.［12］ Broer SL, Dolleman M, Opmeer BC, et al. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis［J］. Hum Reprod Update,2011,17(1):46-54.［13］ Fleming R, Kelsey TW, Anderson RA, et al. Interpreting human follicular recruitment and antimullerian hormone concentrations throughout life［J］. Fertil Steril,2012,98(5):1097-1102.［14］ Ficicioglu C, Cenksoy PO, Yildirim G, et al. Which cut-off value of serum anti-Mullerian hormone level can predict poor ovarian reserve, poor ovarian response to stimulation and in vitro fertilization success?-a prospective data analysis［J］. Gynecol Endocrinol,2014,30(5):372-376.［15］ Gnoth C, Schuring AN, Friol K, et al. Relevance of anti-Mullerian hormone measurement in a routine IVF program［J］. Hum Reprod,2008,23(6):1359-1365.［16］ Nelson SM, La Marca A. The journey from the old to the new AMH assay: how to avoid getting lost in the values［J］. Reprod Biomed Online,2011,23(4):411-420.［17］ Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria［J］. Hum Reprod,2011,26(7):1616-1624.［18］ Chen QJ, Sun XX, Li L, et al. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH)［J］. Acta Obstet Gynecol Scand,2007,86(7):849-854.［19］ Jayaprakasan K, Campbell B, Hopkisson J, et al. A prospective, comparative analysis of anti-Mullerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation［J］. Fertil Steril,2010,93(3):855-864.［20］ Oliveira JB, Baruffi RL, Petersen CG, et al. A new ovarian response prediction index (ORPI): implications for individualised controlled ovarian stimulation［J］. Reprod Biol Endocrinol,2012,10:94-99. |
